Jan 9
Ascendis Pharma A/S (ASND) Goes Over Week 52 Topline Arise From Train Test Examining TransCon CNP and Development Hormonal Agent in Achondroplasia Records
Adhere To Play Revenues Call Play Revenues Call Ascendis Pharma A/S (ASND) Goes Over Week 52 Topline Arise From Train Test Examining TransCon CNP and Development Hormonal Agent in Achondroplasia January 8, 2026 4:30 PM EST Firm Individuals Scott Smith – CFO, Exec VP & & Participant of Exec Board Jan Mikkelsen – Head Of State, CHIEF EXECUTIVE OFFICER, Participant of Exec Board & & Exec…
